Biological Products, (No Diagnostic Substances) · DE · CIK 1706431
VIR Biotechnology develops and seeks approval for novel therapeutic product candidates through extensive clinical studies
Comparable business profile · signals at a glance
In the 90 days to Mar 23, 2026: 6 sold $1.6M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 23, 2026 | Sabatini BrentSVP, Chief Accounting Officer | Sell | 7,711 | $9.12 | $70K |
| Mar 2, 2026 | Sato Vicki LDirector | Sell | 21,800 | $9.50 | $207K |
| Mar 2, 2026 | Sato Vicki LDirector | Sell | 200 | $9.98 | $2K |
| Feb 25, 2026 | De Verneuil VaninaEVP, General Counsel, Corp Sec | Sell | 13,700 | $9.82 | $135K |
| Feb 25, 2026 | Eisner MarkEVP and Chief Medical Officer | Sell | 1,889 | $9.82 | $19K |
| Feb 24, 2026 | Sato Vicki LDirector | Sell | 42,177 | $9.75 | $411K |
| Feb 24, 2026 | De Backer MarianneChief Executive Officer | Sell | 14,762 | $9.53 | $141K |
| Feb 24, 2026 | De Verneuil VaninaEVP, General Counsel, Corp Sec | Sell | 3,117 | $9.53 | $30K |
| Feb 24, 2026 | O'Byrne JasonEVP & Chief Financial Officer | Sell | 1,634 | $9.53 | $16K |
| Feb 24, 2026 | Eisner MarkEVP and Chief Medical Officer | Sell | 1,616 | $9.53 | $15K |
| Feb 24, 2026 | Sabatini BrentSVP, Chief Accounting Officer | Sell | 1,430 | $9.53 | $14K |
| Feb 24, 2026 | Sato Vicki LDirector | Sell | 200 | $10.26 | $2K |
| Feb 23, 2026 | De Backer MarianneChief Executive Officer | Sell | 19,039 | $7.45 | $142K |
| Feb 23, 2026 | De Verneuil VaninaEVP, General Counsel, Corp Sec | Sell | 4,445 | $7.45 | $33K |
| Feb 23, 2026 | Eisner MarkEVP and Chief Medical Officer | Sell | 2,089 | $7.45 | $16K |
| Feb 23, 2026 | O'Byrne JasonEVP & Chief Financial Officer | Sell | 2,089 | $7.45 | $16K |
| Feb 23, 2026 | Sabatini BrentSVP, Chief Accounting Officer | Sell | 1,829 | $7.45 | $14K |
| Feb 13, 2026 | Sabatini BrentSVP, Chief Accounting Officer | Sell | 1,530 | $7.79 | $12K |
| Feb 2, 2026 | Sato Vicki LDirector | Sell | 22,000 | $7.71 | $170K |
| Jan 2, 2026 | Sato Vicki LDirector | Sell | 22,000 | $5.93 | $130K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.